Indications and uses
For the treatment of warts
For the treatment of warts
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Warts will dry and flake away over 3 to 6 week period. Store at room temperature.
Thuja Occidentalis
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States
Wart Symptom Relief
For the treatment of warts
For external use only.
Ask a doctor before use if pregnant or nursing.
When using this product, do not get into eyes.
If swallowed, call poison control or seek medical help.
Wash and dry affected skin. Apply a thin layer of Terrasil. Repeat procedure 2-3 times daily until skin improves. Warts will dry and flake away over 3 to 6 week period. Store at room temperature.
cera alba (organic beeswax), juniperus virginiana (cedarwood) oil, silver oxide, magnesium oxide, simmondsia chinensis (jojoba) seed oil, zinc oxide
terrasil
Wart Treatment
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24909-113-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-66fd-f424-e053-dadaa90a57ce | Drug Facts |
| 24909-113-44 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-66fd-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24909-113-14 | Terrasil Wart Treatment | 14 g in 1 JAR | OINTMENT | 14 | 2 | |
| 24909-113-44 | Terrasil Wart Treatment | 44 g in 1 JAR | OINTMENT | 44 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 2 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 2 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 2 | |
| JUNIPERUS VIRGINIANA OIL | INACTIVE INGREDIENT | PAD4FN7P2G | 2 | |
| MAGNESIUM OXIDE | INACTIVE INGREDIENT | 3A3U0GI71G | 2 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 2 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | 2 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24909-113 | 24909-113-14, 24909-113-44 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| JOJOBA OIL | 724GKU717M | IACT |
| JUNIPERUS VIRGINIANA OIL | PAD4FN7P2G | IACT |
| MAGNESIUM OXIDE | 3A3U0GI71G | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| WHITE WAX | 7G1J5DA97F | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / SUBLINGUAL | 15 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE, EXTENDED RELEASE / ORAL | 71 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / ORAL | 63 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, DELAYED RELEASE / ORAL | 0.08 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, FILM COATED / ORAL | 80 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, COATED / ORAL | 3 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM, AUGMENTED / TOPICAL | 10 %w/w | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE / ORAL | 20 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET / ORAL | 5 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, DELAYED RELEASE / ORAL | 368 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | GUM, CHEWING / BUCCAL | 173 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / VAGINAL | 40 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, EXTENDED RELEASE / ORAL | 75 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / TOPICAL | 500 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, EXTENDED RELEASE / ORAL | 25.74 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT, AUGMENTED / TOPICAL | 429 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE / ORAL | 79 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | LOTION / TOPICAL | 1 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, DELAYED RELEASE / ORAL | 78 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | SUPPOSITORY / RECTAL | 265 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b123b66a-a506-4ca4-8192-b0b4d1f2ce5b | 69b755d5-626d-4b74-8684-e8e55a709e85 | 2012-09-19 | Warnings | b123b66a-a506-4ca4-8192-b0b4d1f2ce5b 69b755d5-626d-4b74-8684-e8e55a709e85 |
Adverse event summaries are temporarily unavailable. Other product information remains available.